% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hesse:1046238,
author = {Hesse, Robert and Gertzen, Christoph G. W. and Schmuck,
Jessica Felice and Böcker, Justin Darvin and Pandey, Piyush
and Behn, Tobias and Ruth, Christopher and Riesner, Detlev
and Kath-Schorr, Stephanie and Lang, Philipp A. and Gohlke,
Holger and Etzkorn, Manuel},
title = {{T}he coming of age of {DNA}‐based catalysts for
therapeutic applications},
journal = {Clinical and translational medicine},
volume = {15},
number = {7},
issn = {2001-1326},
address = {Hoboken, NJ},
publisher = {Wiley},
reportid = {FZJ-2025-03758},
pages = {e70408},
year = {2025},
abstract = {DNA enzymes, also known as DNAzymes (Dz), are synthetic
high-precision biocatalysts that have been identified by in
vitro selection three decades ago.1 Dz are usually short,
single-stranded DNA molecules that catalyse chemical
reactions through their specific three-dimensional
structure.2 Due to their enormous therapeutic potential,
particular interest has been invested in RNA-cleaving Dz,
such as the 8–17 Dz and 10–23 Dz2. In general, these
DNAzymes share a modular architecture comprising a
(conserved) catalytic loop sequence and adaptable substrate
binding arm sequences that, following specific design
guidelines, can be modified to bind virtually any given
target RNA with high selectivity.},
cin = {IBG-4 / IBI-7},
ddc = {610},
cid = {I:(DE-Juel1)IBG-4-20200403 / I:(DE-Juel1)IBI-7-20200312},
pnm = {2171 - Biological and environmental resources for
sustainable use (POF4-217) / 5241 - Molecular Information
Processing in Cellular Systems (POF4-524)},
pid = {G:(DE-HGF)POF4-2171 / G:(DE-HGF)POF4-5241},
typ = {PUB:(DE-HGF)16},
pubmed = {40660744},
UT = {WOS:001528967100001},
doi = {10.1002/ctm2.70408},
url = {https://juser.fz-juelich.de/record/1046238},
}